Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus

被引：0
|
作者：
Hai-Feng Pan
Rui-Xue Leng
Ning Zhang
Jin-Hui Tao
Dong-Qing Ye
机构：
[1] Anhui Medical University,Department of Epidemiology and Biostatistics, School of Public Health
[2] Anhui Provincial Hospital,Department of Rheumatology
来源：
Rheumatology International | 2011年 / 31卷
关键词：
Glycodelin A; Systemic lupus erythematosus; Therapeutic target;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glycodelin A (GdA) is a lipocalin with an immunomodulatory role. Low expression of GdA has been implicated in the progression of autoimmune disease. Therefore, strategies targeting GdA may constitute an important target for the design of drugs for autoimmune disease including systemic lupus erythematosus (SLE). This opinion article will focus on current understanding of the role of GdA in the physiological and pathological functions associated with SLE. It is the intention of the article to provide insights that may assist in the development of GdA-based approaches for the treatment of SLE.
引用
收藏
页码：563 / 565
页数：2
相关论文
共 50 条
  • [31] GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus
    Xu, Wang-Dong
    Huang, Qi
    Yang, Chan
    Li, Rong
    Huang, An-Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
    Barati, Michelle T.
    Caster, Dawn J.
    METABOLITES, 2022, 12 (02)
  • [33] Interleukin-21, a potential diagnostic and therapeutic target for systemic lupus erythematosus
    He, Yong
    Huang, Cheng
    Zhang, Lei
    Lv, Xiong-wen
    Li, Jun
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (07) : 1027 - 1028
  • [34] Systemic lupus erythematosus: news and therapeutic perspectives
    Sibilia, Jean
    Pasquali, Jean-Louis
    PRESSE MEDICALE, 2008, 37 (03): : 444 - 459
  • [35] New therapeutic approaches in systemic lupus erythematosus
    Kolios, Antonios G. A.
    Yoshida, Nobuya
    Tsokos, George C.
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (02) : 181 - 189
  • [36] Newer therapeutic approaches for systemic lupus erythematosus
    Ginzler, EM
    Dvorkina, O
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (02) : 315 - +
  • [37] Systemic lupus erythematosus: Future therapeutic avenues
    Amoura, Z.
    Haroche, J.
    Piette, J. -C.
    REVUE DE MEDECINE INTERNE, 2008, 29 (09): : 718 - 724
  • [38] THERAPEUTIC PROSPECTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    LAVILLE, M
    ELHABIB, R
    TRAEGER, J
    PRESSE MEDICALE, 1985, 14 (26): : 1431 - 1431
  • [39] Systemic lupus erythematosus with thyroiditis:: A therapeutic dilemma?
    Jakez-Ocampo, J
    Richaud-Patin, Y
    Llorente, L
    Pérez, B
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (01) : 114 - 115
  • [40] Novel therapeutic agents for systemic lupus erythematosus
    Gescuk, BD
    Davis, JC
    CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (05) : 515 - 521
12345